149
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Performance of Metagenomic Next-Generation Sequence in the Diagnosis of Suspected Opportunistic Infections in Patients with Acquired Immunodeficiency Syndrome

, , , , , & show all
Pages 5645-5653 | Received 12 Jun 2022, Accepted 29 Aug 2022, Published online: 24 Sep 2022

References

  • Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA. 2006;296(3):292–300. doi:10.1001/jama.296.3.292
  • Iroezindu MO. Disparities in the magnitude of human immunodeficiency virus-related opportunistic infections between high and low/middle-income countries: Is highly active antiretroviral therapy changing the trend? Ann Med Health Sci Res. 2016;6(1):4–18. doi:10.4103/2141-9248.180234
  • WHO Guidelines Approved by the Guidelines Review Committee. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015.
  • Ramesh K, Gandhi S, Rao V. Clinical profile of human immunodeficiency virus patients with opportunistic infections: a descriptive case series study. Int J Appl Basic Med Res. 2015;5(2):119–123. doi:10.4103/2229-516X.157166
  • Scott L, da Silva P, Boehme CC, Stevens W, Gilpin CM. Diagnosis of opportunistic infections: HIV co-infections - tuberculosis. Curr Opin HIV AIDS. 2017;12(2):129–138. doi:10.1097/COH.0000000000000345
  • Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR–4):1–207.
  • Solomon FB, Angore BN, Koyra HC, Tufa EG, Berheto TM, Admasu M. Spectrum of opportunistic infections and associated factors among people living with HIV/AIDS in the era of highly active anti-retroviral treatment in Dawro Zone hospital: a retrospective study. BMC Res Notes. 2018;11(1):604. doi:10.1186/s13104-018-3707-9
  • Pang W, Shang P, Li Q, et al. Prevalence of opportunistic infections and causes of death among hospitalized HIV-infected patients in Sichuan, China. Tohoku J Exp Med. 2018;244(3):231–242. doi:10.1620/tjem.244.231
  • Luo B, Sun J, Cai R, et al. Spectrum of opportunistic infections and risk factors for in-hospital mortality of admitted AIDS patients in Shanghai. Medicine. 2016;95(21):e3802. doi:10.1097/MD.0000000000003802
  • Mazuski JE, Sawyer RG, Nathens AB, et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt). 2002;3(3):175–233. doi:10.1089/109629602761624180
  • Thorndike J, Kollef MH. Culture-negative sepsis. Curr Opin Crit Care. 2020;26(5):473–477. doi:10.1097/MCC.0000000000000751
  • Paul M, Kariv G, Goldberg E, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2010;65(12):2658–2665. doi:10.1093/jac/dkq373
  • Campion M, Scully G. Antibiotic use in the intensive care unit: optimization and de-escalation. J Intensive Care Med. 2018;33(12):647–655. doi:10.1177/0885066618762747
  • Yang L, Haidar G, Zia H, et al. Metagenomic identification of severe pneumonia pathogens in mechanically-ventilated patients: a feasibility and clinical validity study. Respir Res. 2019;20(1):265. doi:10.1186/s12931-019-1218-4
  • Chen X, Cao K, Wei Y, et al. Metagenomic next-generation sequencing in the diagnosis of severe pneumonias caused by Chlamydia psittaci. Infection. 2020;48(4):535–542. doi:10.1007/s15010-020-01429-0
  • Chen J, He T, Li X, Wang X, Peng L, Ma L. Metagenomic next-generation sequencing in diagnosis of a case of pneumocystis jirovecii pneumonia in a kidney transplant recipient and literature review. Infect Drug Resist. 2020;13:2829–2836. doi:10.2147/IDR.S257587
  • Carpenter ML, Tan SK, Watson T, et al. Metagenomic next-generation sequencing for identification and quantitation of transplant-related DNA viruses. J Clin Microbiol. 2019;57(12):12. doi:10.1128/JCM.01113-19
  • Jerome H, Taylor C, Sreenu VB, et al. Metagenomic next-generation sequencing aids the diagnosis of viral infections in febrile returning travellers. J Infect. 2019;79(4):383–388. doi:10.1016/j.jinf.2019.08.003
  • Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis. 2018;67(suppl_2):S231–s240. doi:10.1093/cid/ciy693
  • Zhang Y, Cui P, Zhang HC, et al. Clinical application and evaluation of metagenomic next-generation sequencing in suspected adult central nervous system infection. J Transl Med. 2020;18(1):199. doi:10.1186/s12967-020-02360-6
  • Simner PJ, Buckwalter SP, Uhl JR, Wengenack NL. Identification of Mycobacterium species and Mycobacterium tuberculosis complex resistance determinants by use of PCR-electrospray ionization mass spectrometry. J Clin Microbiol. 2013;51(11):3492–3498. doi:10.1128/JCM.01408-13
  • Hodowanec AC, Pikis A, Komatsu TE, et al. Treatment and prevention of CMV disease in transplant recipients: current knowledge and future perspectives. J Clin Pharmacol. 2019;59(6):784–798. doi:10.1002/jcph.1363
  • Yu S, Yang Q, Wu J, et al. Clinical application of Epstein-Barr virus DNA loads in Epstein-Barr virus-associated diseases: a cohort study. J Infect. 2021;82(1):105–111. doi:10.1016/j.jinf.2020.11.027
  • Fang X, Mei Q, Fan X, et al. Diagnostic value of metagenomic next-generation sequencing for the detection of pathogens in bronchoalveolar lavage fluid in ventilator-associated pneumonia patients. Front Microbiol. 2020;11:599756. doi:10.3389/fmicb.2020.599756
  • Jiang J, Bai L, Yang W, et al. Metagenomic next-generation sequencing for the diagnosis of pneumocystis Jirovecii pneumonia in non-HIV-infected patients: a retrospective study. Infect Dis Ther. 2021;10(3):1733–1745. doi:10.1007/s40121-021-00482-y
  • Cao Q, Chen B, Chen L, et al. Expert consensus on the clinical application of metagenomics next-generation sequencing technology for detection of infectious pathogens in China. Chin J Infect Dis. 2020;38(11):681–689. doi:10.3760/cma.j.cn311365-20200731-00732
  • Peng JM, Du B, Qin HY, Wang Q, Shi Y. Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients. J Infect. 2021;82(4):22–27. doi:10.1016/j.jinf.2021.01.029
  • Liu L, Yuan M, Shi Y, Su X. Clinical performance of BAL metagenomic next-generation sequence and serum (1,3)-β-D-glucan for differential diagnosis of Pneumocystis jirovecii Pneumonia and Pneumocystis jirovecii colonisation. Front Cell Infect Microbiol. 2021;11:784236. doi:10.3389/fcimb.2021.784236
  • Han D, Li Z, Li R, Tan P, Zhang R, Li J. mNGS in clinical microbiology laboratories: on the road to maturity. Crit Rev Microbiol. 2019;45(5–6):668–685. doi:10.1080/1040841X.2019.1681933